Gland Pharma enters into a Put Option Agreement to acquire 100 per cent of Cenexi Group
The proposed acquisition remains subject to receipt of necessary regulatory approvals and satisfaction of certain conditions
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gland Pharma
Dr Reddy’s launches Ertapenem for Injection in US
Dr Reddy’s Ertapenem for Injection, 1 g/vial, is available in packs of 10 vials per carton
Gland Pharma gets US FDA nod for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion
Foscarnet Sodium Injection is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS
Gland Pharma signs deal with RDIF for 252 million Sputnik V vaccine doses
Gland Pharma said it would explore more deals for the vaccine
Dr Reddy’s launches OTC Olopatadine Hydrochloride Ophthalmic Solution in US
They are indicated for the temporary relief of eye allergies like itchy eyes due to pollen, ragweed, grass, animal hair and dander
Gland Pharma files DRHP with SEBI
The Initial Public Offer (IPO) comprises of a fresh issue aggregating up to Rs. 12,500 million (the “Fresh Issue”) and an offer…
Gland Pharma launches of the first non-frozen ready-to-use Bivalirudin
Bivalirudin RTU Injection is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention